Agno Pharmaceuticals is a global small molecule CDMO supplying critical RSMs, intermediates, active pharmaceutical ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations to large and medium-sized pharmaceutical, biotech, generic and CDMO customers. Founded in 2004, Agno has process development and US-FDA inspected GMP-compliant manufacturing facilities with sterile suspension injectable manufacturing capabilities. In addition, Agno has established a drug product formulation research and development laboratory for complex injectables. Agno Pharmaceuticals has invested in its people and facilities and established a broad spectrum of service capabilities throughout the entire drug development and commercialization process. Agno Pharmaceuticals has an excellent track record in the delivery of both development and commercial stage cGMP manufacturing solutions to its customers in North America and Europe.
View Top Employees from Agno PharmaWebsite | http://www.agnopharma.com |
Revenue | $24 million |
Employees | 21 (11 on RocketReach) |
Founded | 2004 |
Address | 3894 Courtney St, Bethlehem, Pennsylvania 18017, US |
Phone | (212) 574-4825 |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 17 Million |
Keywords | Mestanolone Pharma Product, Agno Pharma, Cmo Pharmaceutical List China |
Competitors | Biovian, Famar Lyon, Florida Supplement, GBI Bio, UPM Pharmaceuticals |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Agno Pharma employee's phone or email?
The Agno Pharma annual revenue was $24 million in 2024.
11 people are employed at Agno Pharma.
Agno Pharma is based in Bethlehem, Pennsylvania.
The NAICS codes for Agno Pharma are [325, 32, 32541, 3254].
The SIC codes for Agno Pharma are [283, 28].